Cargando…
Novel targets, treatments, and advanced models for intracerebral haemorrhage
Intracerebral haemorrhage (ICH) is the second most common type of stroke and a major cause of mortality and disability worldwide. Despite advances in surgical interventions and acute ICH management, there is currently no effective therapy to improve functional outcomes in patients. Recently, there h...
Autores principales: | Zille, Marietta, Farr, Tracy D., Keep, Richard F., Römer, Christine, Xi, Guohua, Boltze, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850756/ https://www.ncbi.nlm.nih.gov/pubmed/35158309 http://dx.doi.org/10.1016/j.ebiom.2022.103880 |
Ejemplares similares
-
Pharmacologically targeting inflammation and improving cerebrospinal fluid circulation improves outcome after subarachnoid haemorrhage
por: Zille, Marietta, et al.
Publicado: (2022) -
Intracerebral haemorrhage: an often neglected medical emergency
por: Marietta, M., et al.
Publicado: (2007) -
Brain iron overload following intracranial haemorrhage
por: Garton, Thomas, et al.
Publicado: (2016) -
Treating supratentorial intracerebral haemorrhage: hopeless? Or rethink our strategy
por: Wang, David Z, et al.
Publicado: (2021) -
Neuronal Stem Cell and Drug Interactions: A Systematic Review and Meta‐Analysis: Concise Review
por: Ikhsan, Maulana, et al.
Publicado: (2019)